EGF样域蛋白7(EGFL7)重组蛋白
Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7)
ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7
- 编号RPL643Mu02
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位n/a
- 预测分子量-
- 实际分子量-(差异分析请参阅说明书)
- 片段与标签N-terminal His Tag
- 缓冲液成份磷酸盐缓冲液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性状冻干粉
- 纯度> 97%
- 等电点-
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 840¥ 2100¥ 4200¥ 12600¥ 31500
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
通过ISO 9001、ISO 13485质量体系认证
序列
用法
PBS或其它。
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPL643Mu01 | EGF样域蛋白7(EGFL7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPL643Mu02 | EGF样域蛋白7(EGFL7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAL643Mu02 | EGF样域蛋白7(EGFL7)多克隆抗体 | WB; IHC; ICC; IP. |
| PAL643Mu01 | EGF样域蛋白7(EGFL7)多克隆抗体 | WB,IHC |
| SEL643Mu | EGF样域蛋白7(EGFL7)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LML643Mu | EGF样域蛋白7(EGFL7)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab[PMC5443778] |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.[pubmed:28539619] |
| International Journal of Clinical and Experimental Pathology | EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells[ISSN:1936-2625] |
| Cancer Drug Resist | MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy[] |